Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H14N2 |
Molecular Weight | 102.1781 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCCN
InChI
InChIKey=IUNMPGNGSSIWFP-UHFFFAOYSA-N
InChI=1S/C5H14N2/c1-7(2)5-3-4-6/h3-6H2,1-2H3
Molecular Formula | C5H14N2 |
Molecular Weight | 102.1781 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Chromosome targeting at short polypurine sites by cationic triplex-forming oligonucleotides. | 2001 Oct 19 |
|
NMR characterization of the DNA binding properties of a novel Hoechst 33258 analogue peptide building block. | 2002 Sep-Oct |
|
The role of 3-dimethylaminopropylamine and amidoamine in contact allergy to cocamidopropylbetaine. | 2003 Apr |
|
Migration of methyl groups between aliphatic amines in water. | 2003 Jan 15 |
|
[Functionalization of oligonucleotides containing internucleotide phosphoamide bonds]. | 2003 Jan-Feb |
|
Allergic contact dermatitis from cocamidopropyl betaine, cocamidoamine, 3-(dimethylamino)propylamine, and oleamidopropyl dimethylamine: co-reactions or cross-reactions? | 2004 Sep |
|
Synthesis and characterization of a trifunctional aminoamide cellulose derivative. | 2006 Jan |
|
An efficient vector for gene delivery: alpha,beta-poly (3-dimethylaminopropyl-D,L-aspartamide). | 2007 Jun |
|
Amended final report of the safety assessment of cocamidopropylamine oxide. | 2008 |
|
A study of the sensitization rate to cocamidopropyl betaine in patients patch tested in a university hospital of Beijing. | 2008 Jan |
|
Dichlorido[3-dimethyl-amino-N-(2-pyridylmethyl-ene)propyl-amine-κN,N',N'']cadmium(II). | 2008 Nov 8 |
|
Eyelid dermatitis: contact allergy to 3-(dimethylamino)propylamine. | 2008 Nov-Dec |
|
DNA interaction with PtCl2(LL) (LL = chelating diamine ligand: N,N-dimethyltrimethylendiamine) complex. | 2009 Jul |
|
A new in vitro method for identifying chemical sensitizers combining peptide binding with ARE/EpRE-mediated gene expression in human skin cells. | 2010 Sep |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:14:20 GMT 2023
by
admin
on
Fri Dec 15 19:14:20 GMT 2023
|
Record UNII |
I98I2UEC03
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
I98I2UEC03
Created by
admin on Fri Dec 15 19:14:20 GMT 2023 , Edited by admin on Fri Dec 15 19:14:20 GMT 2023
|
PRIMARY | |||
|
109-55-7
Created by
admin on Fri Dec 15 19:14:20 GMT 2023 , Edited by admin on Fri Dec 15 19:14:20 GMT 2023
|
PRIMARY | |||
|
Dimethylaminopropylamine
Created by
admin on Fri Dec 15 19:14:20 GMT 2023 , Edited by admin on Fri Dec 15 19:14:20 GMT 2023
|
PRIMARY | |||
|
I98I2UEC03
Created by
admin on Fri Dec 15 19:14:20 GMT 2023 , Edited by admin on Fri Dec 15 19:14:20 GMT 2023
|
PRIMARY | |||
|
5391
Created by
admin on Fri Dec 15 19:14:20 GMT 2023 , Edited by admin on Fri Dec 15 19:14:20 GMT 2023
|
PRIMARY | |||
|
7993
Created by
admin on Fri Dec 15 19:14:20 GMT 2023 , Edited by admin on Fri Dec 15 19:14:20 GMT 2023
|
PRIMARY | |||
|
1067
Created by
admin on Fri Dec 15 19:14:20 GMT 2023 , Edited by admin on Fri Dec 15 19:14:20 GMT 2023
|
PRIMARY | |||
|
203-680-9
Created by
admin on Fri Dec 15 19:14:20 GMT 2023 , Edited by admin on Fri Dec 15 19:14:20 GMT 2023
|
PRIMARY | |||
|
DTXSID5025102
Created by
admin on Fri Dec 15 19:14:20 GMT 2023 , Edited by admin on Fri Dec 15 19:14:20 GMT 2023
|
PRIMARY | |||
|
1661327
Created by
admin on Fri Dec 15 19:14:20 GMT 2023 , Edited by admin on Fri Dec 15 19:14:20 GMT 2023
|
PRIMARY | RxNorm |